Unither Pharmaceuticals Completes Enrollment in 1st of 2 Phase III Trials of OvaRex in Advanced Ovarian Cancer
12th Dec 2005, 14:22 GMT
United Therapeutics Corp announced that its wholly owned subsidiary Unither Pharmaceuticals has achieved full enrollment of 177 patients in IMPACT I, the 1st of 2 identical double-blind, placebo-controlled trials of OvaRex in late stage ovarian cancer.
Unither Pharmaceuticals Completes Enrollment in 1st of 2 Phase III Trials of OvaRex in Advanced Ovarian Cancer related news:
- Unither prepares ovarian cancer drug study — Pharmaceutical Business Review Online
- Breast cancer trials set for second phase — bizjournals.com Health Care:Pharmaceuticals headlines
- MedImmune Completes Enrollment in Phase 3 Study Comparing Numax to Synagis — Pharmaceuticals News from StratCenter.com
- SciClone Reports Results From 1st ZADAXIN Phase 3 Hepatitis C Trial — Pharmaceuticals News from StratCenter.com
- ViRexx Announces Enrollment Completion of Ovarex'R' MAb Phase III Trial for Ovarian Cancer — ArriveNet : Health
- MedImmune Completes Enrollment in Phase 3 Study Comparing Numax(TM) to Synagis(R)- Company Also Completes Enrollment in Numax Study in Congenital Heart Disease Patients - — mysan.de
- US Phase III Aridol Trial Enrols 1st Patient — Government/ Industry Regulation News from StratCenter.com
- Race and gender affect lung cancer clinical trial participation — EurekAlert! - Medicine and Health
- Blacks, Women Underrepresented in Lung Cancer Trials: Study (HealthDay) — Yahoo! News: Health News
- Cougar initiates trial of prostate cancer treatment — Pharmaceutical Business Review Online
Latest news from Obstetrics/ Gynecology News from StratCenter.com:
- Acusphere Reports Q3 2006 Financial Results and Accomplishments
- CuraGen and TopoTarget Announce Initiation of NCI-Sponsored Phase II Trial of PXD101 for Ovarian Cancer
- Twin Cities Takes Action to Save Babies
- Substantial Regression of Atherosclerosis May Help Improve Diseased Arteries
- EDAP TMS SA to Participate in Int'l Urology Conferences
- Misonix Showcases SonicOne Ultrasonic Wound Debrider with Medline at MEDICA 2006 in Germany
- 8 Studies Evaluating Cytyc's Novasure System Presented at AAGL Meeting